reported the cloning of a cDNA encoding a cannabinoid re ceptor (CB1) from a rat brain cDNA library. The CBl recep tor is a seven-transmembrane, G protein-coupled receptor, and contains 472 (human) or 473 (rat) amino acids (Table  I) . Later, Munro et al. (4) cloned another cDNA encoding a cannabinoid receptor (CB2) from a promyelocytic leukemia HL-60 cell cDNA library. The CB2 receptor is also a seven transmembrane, G protein-coupled receptor, and consists of 360 amino acids (Table I) . The CBl and CB2 receptors share 44% overall identity (68% identity for the transmem brane domains). Both receptors are coupled to Gi/Go, and various biological responses mediated through them are abolished following treatment of tissues and cells with per tussis toxin. To date, a number of compounds acting on can nabinoid receptors have been synthesized. Several com pounds were found to act as antagonists/inverse agonists: SR141716A (Fig. 1) is a selective antagonistlinverse agonist for the CBl receptor, and SR144528 (Fig. 1) The CB1 receptor is expressed abundantly in the ner vous system and in various peripheral tissues (Table I) . It is noteworthy that the whole-brain cannabinoid receptor density is similar to whole-brain densities of receptors for glutamate and GABA (5). Among the various brain regions, the CBl receptor is especially abundant in the substantia nigra, the globus pallidus, the molecular layer of the cere bellum, the hippocampus, and the cerebral cortex; the CB1 receptor is assumed to be involved in the regulation of cog nition, memory and motor activity (5). On the other hand, the CB2 receptor is almost exclusively present in tissues of the immune system such as the spleen, tonsil and lymph nodes ( Table I ). The CB2 receptor is abundantly expressed in several types of leukocytes such as macrophages/mono cytes, B lymphocytes, and natural killer cells, and is as In addition to acting as an endogenous cannabinoid receptor ligand, anandamide was shown to act as an s , dog: enous ligand for an ion channel-type vanilloid ??
(VR1 receptor). Furthermore, anandamide can also bind to several other types of ion channels. Therefore, it seems pos sible that some of the effects of anandamide mentioned above are mediated through receptors or binding sites other than the cannabinoid receptors. One should keep this in mind when interpreting the experimental results con cerning the biological activities of anandamide.
Biosynthesis and degradation of anandamide. Anandamide can be formed enzymatically via two indepen dent synthetic pathways (7-10). One is the direct N-acyla tion of ethanolamine, and the other is transacylase-phos phodiesterase-mediated synthesis. The first pathway is cat alyzed by the reverse reaction of an anandamide amidohy drolase/fatty acid amide hydrolase (7-11), suggesting that the formation of anandamide via this pathway may not be physiologically relevant, yet there remains the possibility that a significant amount of anandamide can be formed via this pathway if high concentrations of arachidonic acid and ethanolamine are co-localized at certain sites within the cell. The second pathway is the formation of anandamide from pre-existing N-arachidonoyl phosphatidylethanola mine (PE) through the action of a phosphodiesterase. This enzyme reaction has been assumed to be the major syn thetic route for various N-acylethanolamines such as N palmitoyl and N-stearoyl-ethanolamine (12). Several in vestigators have provided evidence that anandamide can be formed from N-arachidonoyl PE through the action of a phosphodiesterase (7-10). This is probably the main syn thetic pathway for anandamide in various mammalian tis sues. However, this pathway does not appear to be able to generate a large amount of anandamide, because the tissue level of N-arachidonyl PE is usually very low. The reason for this is that N-arachidonoyl PE is synthesized from PE and arachidonic acid, and esterified at the 1-position of glycerophospholipids through the action of a transacylase (7-10). Importantly, the level of arachidonic acid esterified at the 1-position of glycerophospholipids is usually very low (7). The absence of efficient synthetic pathways for ananda mide is in agreement with the observation that the tissue levels of anandamide are generally low (the order of pmol/g tissue) except in a few cases (7, 13).
The degradation of anandamide is catalyzed by two sepa rate types of anandamide amidohydrolase/fatty acid amide hydrolase: the optimal pH of one isoform is 8.5-10 (11) and that of the other is 5 (14) . The gene encoding the former enzyme protein has been cloned (15 2-AG exhibits various cannabimimetic activities similar to those of anandamide described before (7-9, 19). Notice ably, 2-AG was found to act as a full agonist at either the CBl receptor or the CB2 receptor in many cases (7, 19) . Based on the results of structure-activity relationship ex periments using neuroblastoma x glioma hybrid NG108-15 cells, which express the CB1 receptor, we deduced that the CBl receptor is originally and primarily a 2-AG receptor. Also, based on the results of structure-activity relationship experiments using HL-60 cells, which express the CB2 re ceptor, we concluded that the CB2 receptor is a 2-AG recep tor (7, 19) . Biosynthesis and degradation of 2-AG. 2-AG is present in relatively large amounts in various mammalian tissues (in the order of nmol/g tissue) (7, 19). Importantly, the levels of 2-AG were elevated rapidly in tissues and cells upon stimulation (7, 19). Furthermore, a significant portion of newly formed 2-AG can be released from stimulated cells (7, 19) . These characteristics appear to be favorable in the action of 2-AG as an intercellular mediator derived from stimulated cells.
Then, how is 2-AG formed in living cells? Previously, we mentioned that 2-AG can be formed from arachidonic acid enriched membrane phospholipids, such as inositol phos pholipids, through the combined actions of phospholipase C and diacylglycerol (DG) lipase or the combined actions of phospholipase A, and phospholipase C (17). The first path way, involving rapid hydrolysis of inositol phospholipids by phospholipase C and subsequent hydrolysis of the resultant DG by DG lipase, was described by Prescott and Majerus two decades ago as a degradation pathway for arachidonic acid-containing DG in platelets (20) . Stella et al. (21) dem onstrated that these enzyme activities are involved in iono mycin-induced generation of 2-AG in cultured neurons using metabolic inhibitors. Recently, we confirmed that this pathway is important for the depolarization-induced gener ation of 2-AG in rat brain synaptosomes (T. Sugiura, un Dublished results).
The second pathway involves hydrolysis of phosphatidyli nositol (PI) by phospholipase A, and hydrolysis of the resultant lysoPI by a specific phospholipase C. Noticeably, T Sugiura and. K. Waku lysoPI-specific phospholipase C is distinct from various types of phospholipase C which act on other inositol phos pholipids, and is localized in the synaptosomes (22) . It is possible, therefore, that this unique enzyme may also be involved in the generation of 2-AG in synapses. In addition to these two pathways, there are several possible routes for the generation of 2-AG, for example, from 2-arachidonoyl LPA (23) or 2-arachidonoyl PA (24) . The biosynthetic path ways for 2-AG appear to differ, depending on the types of tissues and cells, and the types of stimuli. Further detailed studies are necessary for a full understanding of the mech anism and regulation of the biosynthesis of 2-AG.
Like other monoacylglycerols, 2-AG is metabolized by monoacylglycerol lipase. In addition, several investigators have demonstrated that anandamide amidohydrolase/fatty acid amide amidohydrolase is also able to metabolize 2-AG (7, 19). 2-AG may be degraded by anandamide amidohydro lase/fatty acid amide amidohydrolase in addition to monoa cvlelvicerol lipase under some circumstances.
An ether-linked analog of 2-AG. Among the various 2-AG analogs, an ether-linked analog of 2-AG (2-AG ether or HU310) (295-27), is a useful tool in exploring the possible biological activities of 2-AG, especially in vivo, because this compound is quite stable against hydrolyzing enzymes. Recently, Hanus et al. (28) reported that 2-AG ether is present in pig brain (they re-named it "noladin ether"). However, we did not detect 2-AG ether in the rat brain or pig brain (S. Oka and T. Sugiura, unpublished reeults). The ether bond is known to be located exclusively at the 1-posi tion of the glycerol backbone in mammalian tissues (29); whether 2-AG ether is a naturally-occurring molecule should be re-examined. Physiological roles of 2-AG. In contrast to ananda mide, 2-AG was found to act as a full agonist at either the cannabinoid CB1 receptor or the CB2 receptor. Moreover, 2 AG can be produced rapidly and selectively from a variety of cells upon stimulation. Unlike anandamide, 2-AG does not bind to the vanilloid receptor. Recently, we proposed that 2-AG is the endogenous natural ligand of the cannab inoid receptors (7, 19) .
What are the physiological roles of 2-AG? It does not seem possible that the physiological compound 2-AG in duces psychedelic reactions such as heightened sensory awareness, dissociation of ideas, errors in judgment of time and space and hallucinations in normal living animals. The cannabinoid CB1 receptor is mainly present in the presyn apses and is assumed to be involved in the attenuation of neurotransmission (5). We hypothesized that the physio logical role of 2-AG, the natural ligand of the CBl receptor, in the synapse is as follows: 2-AG generated through increased phospholipid metabolism, especially inositol phospholipid breakdown, in neurons (presynapses and/or postsynapses) during accelerated synaptic transmission, plays an important role in calming the excitation of neu ronal cells by acting at the cannabinoid CB1 receptor, thereby diminishing any subsequent neurotransmitter re lease (Fig. 2) (7,19, 30) .
Previously, we found that 2-AG suppresses clepolanza tion-induced rapid elevation of the intracellular free Ca2+ concentrations in differentiated NG108-15 cells (31). Fur thermore, recently, we obtained evidence that a substantial amount of 2-AG was released from rat brain synaptosomes upon depolarization (T. Sugiura, unpublished results). It is thus conceivable that 2-AG, generated from stimulated neurons, attenuates several neuronal cell functions such as neurotransmitter release by reducing the intracellular free Ca2+ concentrations.
Such a negative feedback regulation mechanism should be effective in calming stimulated neu rons after excitation (7, 19, 30) . In any case, the above 2 AG and cannabinoid CBl receptor-dependent negative feedback regulation of neurotransmission could be of great physiological significance, because sustained activation of neuronal cells is known to cause cell exhaustion and may lead to neuronal cell death. It is noteworthy that several investigators have recently provided evidence that endoge nous cannabinoid receptor ligands derived from the post synapse as retrograde messenger molecules play important roles in the attenuation of neurotransmission (32) (33) (34) . Moreover, Stella et al. (21) have reported that 2-AG sup presses long-term potentiation in rat hippocampal slices. Ameri and Simmet (35) also reported that 2-AG reduces neuronal excitability in rat hippocampal slices in a cannab inoid CB1 receptor-dependent manner. Further intensive studies on the physiological roles of 2-AG in the synapses are essential to better understand the regulatory mecha nisms of neurotransmission in the mammalian nervous system.
In addition to its roles in the central nervous system, 2 AG may also play important physiological roles in other biological systems such as the reproductive system and the cardiovascular system. We have demonstrated that human endothelial cells produce and release 2-AG upon stimula tion with thrombin or A23187 (36) . We proposed that 2-AG derived from endothelial cells or peripheral nerve terminals may play an essential role in the vascular system through acting on the CBl receptor (36) . Several investigators have demonstrated that the administration of 2-AG induces hypotension in experimental animals and relaxation of blood vessels in vitro (7, 19); it seems possible that 2-AG acts as an endogenous vasodilator in living animals . 
